Belmont Capital LLC Lowers Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Belmont Capital LLC decreased its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 10.0% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 7,916 shares of the healthcare conglomerate's stock after selling 881 shares during the quarter. UnitedHealth Group accounts for about 0.8% of Belmont Capital LLC's portfolio, making the stock its 17th largest holding. Belmont Capital LLC's holdings in UnitedHealth Group were worth $4,628,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Kathleen S. Wright Associates Inc. acquired a new position in shares of UnitedHealth Group in the 3rd quarter valued at approximately $27,000. Macroview Investment Management LLC raised its position in shares of UnitedHealth Group by 671.4% in the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate's stock valued at $28,000 after buying an additional 47 shares in the last quarter. Bbjs Financial Advisors LLC acquired a new position in shares of UnitedHealth Group in the 2nd quarter valued at approximately $31,000. Global Wealth Strategies & Associates raised its position in shares of UnitedHealth Group by 152.4% in the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate's stock valued at $31,000 after buying an additional 32 shares in the last quarter. Finally, Signature Resources Capital Management LLC grew its holdings in shares of UnitedHealth Group by 40.0% during the 2nd quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate's stock valued at $32,000 after purchasing an additional 18 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on UNH shares. TD Cowen lifted their price target on shares of UnitedHealth Group from $601.00 to $609.00 and gave the company a "buy" rating in a report on Friday, October 18th. Hsbc Global Res lowered shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a report on Thursday, October 17th. UBS Group reduced their price objective on shares of UnitedHealth Group from $680.00 to $650.00 and set a "buy" rating on the stock in a research note on Wednesday, October 16th. Bank of America reduced their price objective on shares of UnitedHealth Group from $675.00 to $650.00 and set a "buy" rating on the stock in a research note on Wednesday, October 16th. Finally, Truist Financial reaffirmed a "buy" rating and issued a $625.00 price objective (down from $640.00) on shares of UnitedHealth Group in a research note on Wednesday, October 16th. Three analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and two have given a strong buy rating to the company's stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $615.53.

UnitedHealth Group Stock Down 2.2 %

Shares of NYSE UNH traded down $12.72 during trading on Tuesday, hitting $576.93. The stock had a trading volume of 3,142,427 shares, compared to its average volume of 3,879,812. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91. The company has a market capitalization of $530.94 billion, a PE ratio of 37.59, a PEG ratio of 1.74 and a beta of 0.58. The firm has a fifty day moving average of $582.31 and a two-hundred day moving average of $551.25.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, beating the consensus estimate of $7.00 by $0.15. The company had revenue of $100.82 billion during the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The firm's revenue for the quarter was up 9.2% on a year-over-year basis. During the same quarter in the prior year, the business earned $6.56 earnings per share. As a group, equities research analysts forecast that UnitedHealth Group Incorporated will post 27.6 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be issued a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.46%. The ex-dividend date is Monday, December 9th. UnitedHealth Group's payout ratio is 54.72%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.